29,056 resources
By Version
By Authority
By Realm
Start Prev Rows 26200 - 26400 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|---|
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.3045 | Microorganism (Hepatitis) | active | 2016-01 | us | sct | |||
ch.fhir.ig.ch-term | R4 | treatmentreason | Treatment Reason | active | 2025-05 | ch | hl7 | sct | ||
ihe.pcc.odh | R4 | obf-datatype-YesNoVS | Yes No VS | draft | 2020-01 | uv | ihe | |||
hl7.fhir.us.odh | R4 | obf-datatype-YesNoVS | Yes No VS | draft | 2020-01 | us | hl7 | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6062 | Observation Result Status Interpretation Codes | active | 2012-01 | us | tho | |||
hl7.fhir.cz.core | R4 | cz-dlpatc-vs | Value set of DLP ATC | trial-use | 2 | 2025-01 | cz | hl7 | internal | |
hl7.fhir.cz.core | R4 | cz-dlplecivelatky-vs | Value set of DLP Lecive latky | trial-use | 2 | 2025-01 | cz | hl7 | internal | |
hl7.fhir.cz.core | R4 | cz-dlplecivepripravky-vs | Value set of DLP Lecive pripravky | trial-use | 2 | 2025-01 | cz | hl7 | internal | |
hl7.fhir.cz.core | R4 | cz-dlpformy-vs | Value set of DLP formy | trial-use | 2 | 2025-01 | cz | hl7 | internal | |
smart.who.int.hiv | R4 | HIV.Config.DE12 | HIV burden of the setting ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE17 | Current PrEP regimen ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE122 | PrEP regimen prescribed ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.PRV.DE2 | HIV prevention intervention ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE514 | HIV status of family member ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.H.DE34 | HIV status of partner or contact ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE225 | Infant HIV status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE115 | HIV status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE230 | Final diagnosis of HIV-exposed infant ValueSet | active | 2025-07 | who | internal | |||
hl7.fhir.cz.core | R4 | cz-nclpmat-vs | Value set of NCLP MAT | trial-use | 2 | 2025-01 | cz | hl7 | internal | |
uk.nhsdigital.r4.test | R4 | a6876ad9-6ac5-431a-980d-b093a07e84d6 | ServiceRequestCategory | draft | 2022-03 | hl7 | sct | |||
smart.who.int.hiv | R4 | HIV.D.DE789 | STI tested for ValueSet | active | 2025-07 | who | internal | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-unit-code | eHealthUnitCodes | active | 2020-10 | dk | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-unit | eHealthUnit | active | 2020-10 | dk | fhir | |||
smart.who.int.hiv | R4 | HIV.D.DE83 | Current ART regimen (first-, second-, or third-line) ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE449 | Pregnant and breastfeeding status at ART start ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE225 | Treatment failure ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE64 | ARV drug regimen received prior to enrolment ValueSet | active | 2025-07 | who | ||||
hl7.fhir.us.pq-cmc-fda | R5 | cmc-comp-section-types-vs | eCTD sections Terminology | trial-use | 2 | brr | 2025-07 | us | hl7 | tho |
smart.who.int.hiv | R4 | HIV.C.DE95 | Alternative PEP backbone regimen ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE101 | Alternative third PEP drug ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE461 | Medications dispensed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE712 | Cervical cancer stage at diagnosis ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE5 | Referred through partner services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE30 | Marital Status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE29 | Hepatitis B diagnosis ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE51 | Hepatitis C diagnosis ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE41 | Pregnancy intention in serodiscordant partnerships ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE37 | Partner is from a key population ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE1 | Reason for PrEP visit ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE74 | Type of contact elicited ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE8 | Type of contact or partner for partner services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE706 | Cervical cancer screening outcome ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE74 | Syphilis diagnosis ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1019 | TB status at ART start ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE446 | Coinfection status at ART start ValueSet | active | 2025-07 | who | internal | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-clinicalimpression-codes | Clinical Impression Codes | active | 2019-02 | dk | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-clinicalimpression-decision-codes | ClinicalImpression Decision Codes | active | 2019-09 | dk | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-clinicalimpression-finding-codes | ClinicalImpression Finding Codes | active | 2019-02 | dk | sct oid | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-clinicalimpression-investigation-item-codes | ClinicalImpression Investigation Item Codes | active | 2024-01 | dk | sct | |||
smart.who.int.hiv | R4 | HIV.D.DE247 | Preventing and treating coinfections ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE13 | Country of birth ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE903 | Medication/drug ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE593 | Medication status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE23 | Outcome from outreach attempt ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE560 | Allergies ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE65 | Existing chronic health conditions ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE146 | ART regimen drug class ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE128 | ART regimen composition ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE183 | EID test number ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE180 | EID sample number ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE186 | EID test number 1 test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE190 | EID test number 2 test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE55 | Facility where client first enrolled in HIV care ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE939 | TB diagnosis result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE897 | WHO functional status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE18 | Gender ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE91 | Gender of infant ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE229 | General care activities recommended ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE6 | Source of gestational age ValueSet | active | 2025-07 | who | internal | |||
hl7.terminology | R5 | adverse-event-clinical-research-grades | Adverse Event Clinical Research Grades | active | 1 | brr | 2023-07 | uv | hl7 | ncit |
smart.who.int.hiv | R4 | HIV.D.DE664 | HPV-DNA cervical cancer screening test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE63 | Location ARV drugs received prior to enrolment ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE162 | HBsAg test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE18 | HBsAg test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE168 | HBV treatment regimen prescribed ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE179 | HCV viral load test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE48 | HCV viral load test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE170 | HCV test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE43 | HCV test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE177 | HCV treatment regimen prescribed ValueSet | active | 2025-07 | who | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-situation-quality | Situation Quality | active | 2019-02 | dk | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-usage-quality | Usage Quality | active | 2019-02 | dk | ||||
smart.who.int.hiv | R4 | HIV.D.DE947 | TB treatment history ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE5 | Referred by ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE46 | Communication preference(s) ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE444 | ART regimen prescribed ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE1002 | TB treatment outcome ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1034 | TB preventive treatment (TPT) status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE127 | Infant feeding practice ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE731 | Invasive cervical cancer treatment method ValueSet | active | 2025-07 | who | internal | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-consent-category | Consent Category | active | 2019-02 | dk | ||||
smart.who.int.hiv | R4 | HIV.D.DE90 | ART regimen ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE537 | Current medications ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE112 | Contraindications to PrEP usage ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE63 | Screenings and diagnostics for PrEP users ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE173 | Maternal and child health service visit ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE75 | Medications prescribed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE569 | Family planning method used ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE942 | Method of TB diagnosis ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE13 | Contact method ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE52 | Delivery mode ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE246 | Blood group and Rh factor ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE399 | Monitoring examinations ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE52 | Facility transferred from ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.H.DE50 | Transfer to facility ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE120 | Site where positive HIV test confirmed ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE457 | Medications prescribed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE485 | New regimen after switch to second-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE491 | New regimen after switch to third-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE489 | New regimen(s) after substitution within second-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE495 | New regimen(s) after substitution within third-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE483 | New antiretroviral regimen after substitution within first-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE289 | WHO HIV clinical stage condition or symptom ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE934 | WHO HIV clinical stage condition or symptom ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE172 | Other support services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE164 | Other support services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE519 | Other support services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE152 | Prevention services offered and referrals ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE149 | Prevention services offered and referrals ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE131 | Prevention services offered and referrals ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE158 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE149 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE156 | Sexual and reproductive health integrated services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE74 | Original first-line ART regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.B.DE165 | Offer other clinical services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE157 | Offer other clinical services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE753 | Offer other clinical services ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.Config.DE19 | Other priority populations ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.E.DE47 | Pregnancy outcome ValueSet | active | 2025-07 | who | internal | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-modifier-role | Modifier Role | active | 2019-02 | dk | ||||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-plandefinition-recommendation | PlanDefinition Recommendation | active | 2019-02 | dk | ||||
smart.who.int.hiv | R4 | HIV.C.DE80 | PrEP product prescribed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE91 | Preferred PEP backbone regimen ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE99 | Preferred third PEP drug ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE121 | Probable route of transmission ValueSet | active | 2025-07 | who | internal | |||
dk.ehealth.sundhed.fhir.ig.core | R4 | ehealth-questionnaire-recommendation | QuestionnaireRecommendation | active | 2019-02 | dk | ||||
smart.who.int.hiv | R4 | HIV.D.DE217 | Reason ART stopped ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE1 | Reason for visit ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE636 | Reason immunization was not provided ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE370 | Reasons for delayed ART initiation ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE22 | Reason Hepatitis B test not conducted ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE35 | Reason Hepatitis C test not done ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE418 | Reason for ARV drug regimen substitution ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE430 | Reason for regimen switch ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE62 | Reason syphilis test not done ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE74 | Reason ART stopped ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE53 | Reason(s) for adherence problem ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE197 | Reason(s) for adherence problem ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE486 | Reason for switch to second-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE492 | Reason for switch to third-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE532 | Reason blood pressure reading not done ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.I.DE2 | Reason for referral ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE646 | Reason malaria prophylaxis not provided ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE488 | Reason(s) for substitution within second-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE494 | Reason(s) for substitution within third-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE482 | Reason(s) for substitution within first-line regimen ValueSet | active | 2025-07 | who | ||||
smart.who.int.hiv | R4 | HIV.D.DE986 | TB screening result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE256 | Gonorrhoea test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE808 | Gonorrhoea test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE312 | STI test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE864 | STI test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE325 | Confirmatory STI test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE877 | Confirmatory STI test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE149 | Maternal syphilis test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE250 | Syphilis test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE802 | Syphilis test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.G.DE70 | Syphilis test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE691 | Cervical cancer colposcopy result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE697 | Cervical cancer histopathology result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE179 | Intimate partner violence enquiry results ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE255 | Asymptomatic bacteriuria (ASB) test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE44 | HIV self-test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE259 | Urine protein test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE237 | STI tested for ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE956 | TB screening algorithm ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE673 | Cervical cytology screening test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE668 | VIA cervical cancer screening test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE201 | Adverse event severity ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.A.DE25 | Sex ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE259 | Risk factors, comorbidities and coinfections signs and symptoms ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE17 | Signs of serious illness ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE36 | Signs of substantial risk of HIV infection ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE155 | Signs of substantial risk of HIV infection ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.H.DE17 | Source of information ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE18 | Entry point for community-level testing ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE22 | Entry point for facility-level testing ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE746 | Entry point for facility-level testing ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE893 | Staging of liver disease ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.C.DE46 | Acute HIV infection symptoms ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE973 | Symptoms of TB ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE226 | Syndrome/STI diagnosed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE778 | Syndrome/STI diagnosed ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE1010 | TB treatment regimen composition ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE104 | Maternal HIV test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.D.DE688 | HPV16/18 test result ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE136 | Partner HIV status (confirmed) ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.PRV.DE11 | HIV status of contact ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.B.DE33 | Partner HIV status (reported) ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE141 | Maternal HIV status ValueSet | active | 2025-07 | who | internal | |||
smart.who.int.hiv | R4 | HIV.E.DE145 | Maternal HIV status at first ANC visit ValueSet | active | 2025-07 | who | internal |